Arab Health features everything from highly sophisticated medical devices to simple consumable items. The fair attracts more than 4,300 exhibitors from over 64 countries, and more than 106,000 visitors are expected. Thirty-seven countries will be present with their own pavilion. Calmark"s platform will be presented in "The Innovation Pavilion by Sweden", Za"abeel Hall 2, Stand Z2.A10 at the Dubai International Convention & Exhibition Centre in Dubai, between 27 and 30 January 2020.

The participation in Arab Health represents the starting point for global marketing activities. Marianne Alksnis, International Sales Director, and Anna Söderlund, CEO of Calmark, will be present at the exhibition to meet with participants that have shown interest in the company and initiate discussions with new prospective distributors. 

"Arab Health opens the door to new markets, and the timing could not be better considering our forthcoming CE Mark approval and sales launch," says Marianne Alksnis. "Many distributors choose to go to Arab Health, which has become an important meeting point - not only for the MENA region, but also for other parts of the world, for instance, Asia. Being there gives us the opportunity to establish new partnerships and expand our international network in a region where physical presence is essential."

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
 

For more information about Calmark Sweden AB, please contact:

Anna Söderlund, CEO
Telefon: +46 70 213 25 35
E-post: anna.soderlund@calmark.se 
www.calmark.se 

Calmark Sweden AB is a medical technology company developing a point-of-care (POC) analyzis method with easier and faster sampling of medical conditions in newborns. The unique test platform, which consists of a reader and single-use products, is expected to be ready for launch in 2020 when three important POC tests are introduced. The WHO estimates that 1.5 billion children will be born worldwide by 2030. In the Western world, the introduction of POC diagnostics is resulting in huge savings and shorter healthcare chains. In less developed healthcare systems, the product helps save lives. Calmark aims to become the global leader and ultimately to offer all relevant POC tests for the first period of life, regardless of where in the world a baby is born. Read more about Calmark www.calmark.se/eng/home.